WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) today announced its financial results for the third quarter 2006 and confirmed that it remains on track to demonstrate potential ‘proof-of-concept’ in a number of its most advanced internally developed drug discovery and development programs.
